Intravenous thrombolysis and three ‐year ischemic stroke mortality

ConclusionsTreatment of IS with intravenous recombinant tissue plasminogen activator was associated with increased survival during the three‐year follow‐up.

Source: Acta Neurologica Scandinavica - June 21, 2016 Category: Neurology Authors: K. Chwojnicki, G. Kozera, P. Sobolewski, W. Fryze, W. M. Nyka Tags: Original Article Source Type: research